Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Patients With Chronic Kidney Disease
Clinical trial NCT00436748 · TERMINATED
Trial details
- NCT number
- NCT00436748
- Sponsor
- Amgen
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-16
- Primary completion
- 2014-03-03
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.